SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-18-002112
Filing Date
2018-05-11
Accepted
2018-05-11 13:44:54
Documents
69
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F form20f.htm 20-F 693035
2 EXHIBIT 12.1 exhibit12-1.htm EX-12.1 6696
3 EXHIBIT 12.2 exhibit12-2.htm EX-12.2 6851
4 EXHIBIT 13.1 exhibit13-1.htm EX-13.1 2921
5 EXHIBIT 13.2 exhibit13-2.htm EX-13.2 2927
12 GRAPHIC bdologo.jpg GRAPHIC 2235
  Complete submission text file 0001062993-18-002112.txt   4400151

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE repcf-20171231.xml EX-101.INS 770710
7 XBRL SCHEMA FILE repcf-20171231.xsd EX-101.SCH 76706
8 XBRL CALCULATION FILE repcf-20171231_cal.xml EX-101.CAL 29803
9 XBRL DEFINITION FILE repcf-20171231_def.xml EX-101.DEF 298205
10 XBRL LABEL FILE repcf-20171231_lab.xml EX-101.LAB 480808
11 XBRL PRESENTATION FILE repcf-20171231_pre.xml EX-101.PRE 328938
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-50112 | Film No.: 18826198
SIC: 1040 Gold and Silver Ores